{
    "root": "8e8396fa-288b-402e-82b0-b1007d1b571f",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Ferric Citrate",
    "value": "20240623",
    "ingredients": [
        {
            "name": "TETRAFERRIC TRICITRATE DECAHYDRATE",
            "code": "Q91187K011"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "CALCIUM STEARATE",
            "code": "776XM7047L"
        },
        {
            "name": "HYPROMELLOSE 2910 (6 MPA.S)",
            "code": "0WZ8WG20P6"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "TRIACETIN",
            "code": "XHX3C3X673"
        },
        {
            "name": "FD&C YELLOW NO. 6",
            "code": "H77VEI93A8"
        },
        {
            "name": "FD&C RED NO. 40",
            "code": "WZB9127XOA"
        },
        {
            "name": "FD&C BLUE NO. 2",
            "code": "L06K8R7DQK"
        }
    ],
    "indications": "ferric citrate tablets phosphate binder indicated control serum phosphorus levels adult patients chronic kidney disease dialysis . ( 1 ) ferric citrate tablets iron replacement product indicated treatment iron deficiency anemia adult patients chronic kidney disease dialysis . ( 1 )",
    "contraindications": "• hyperphosphatemia chronic kidney disease dialysis : • starting dose 2 tablets orally 3 times per day meals . ( 2.1 ) • adjust dose 1 2 tablets needed maintain serum phosphorus target levels , maximum 12 tablets daily . dose titrated 1-week longer intervals . ( 2.1 ) • iron deficiency anemia chronic kidney disease dialysis : • starting dose 1 tablet orally 3 times per day meals . ( 2.2 ) • adjust dose needed achieve maintain hemoglobin goal , maximum 12 tablets daily . ( 2.2 )",
    "warningsAndPrecautions": null,
    "adverseReactions": "ferric citrate tablets contraindicated patients iron overload syndromes ( e.g . , hemochromatosis ) [ ( 5.1 ) ] .",
    "indications_original": "Ferric citrate tablets are a phosphate binder indicated for the control of serum phosphorus levels in adult patients with chronic kidney disease on dialysis. ( 1 ) Ferric citrate tablets are an iron replacement product indicated for the treatment of iron deficiency anemia in adult patients with chronic kidney disease not on dialysis. ( 1 )",
    "contraindications_original": "• Hyperphosphatemia in Chronic Kidney Disease on Dialysis: • Starting dose is 2 tablets orally 3 times per day with meals. ( 2.1 ) • Adjust dose by 1 to 2 tablets as needed to maintain serum phosphorus at target levels, up to a maximum of 12 tablets daily. Dose can be titrated at 1-week or longer intervals. ( 2.1 ) • Iron Deficiency Anemia in Chronic Kidney Disease Not on Dialysis: • Starting dose is 1 tablet orally 3 times per day with meals. ( 2.2 ) • Adjust dose as needed to achieve and maintain hemoglobin goal, up to a maximum of 12 tablets daily. ( 2.2 )",
    "adverseReactions_original": "Ferric citrate tablets are contraindicated in patients with iron overload syndromes (e.g., hemochromatosis) [see Warnings and Precautions (5.1)]."
}